Location of Repository

Quality of Life and Neutropenia in Patients with Early Stage Breast Cancer: A Randomized Pilot Study Comparing Additional Treatment with Mistletoe Extract to Chemotherapy Alone

By Wilfried Tröger, Svetlana Jezdić, Zdravko Ždrale, Nevena Tišma, Harald J. Hamre and Miodrag Matijašević
Topics: Original Research
Publisher: Libertas Academica
OAI identifier: oai:pubmedcentral.nih.gov:3086310
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (1991). Additive Therapie mit standardisiertem Mistelextrakt reduziert die Leukopenie und verbessert die Lebensqualität von Patientinnen mit fortgeschrittenem Mammakarzinom unter palliativer Chemotherapie (VEC-Schema).
    2. (2005). Courtens AM. Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol.
    3. (1996). DNA-stabilisierende Wirkungen von Viscum album L.—Sind Mistelextrakte als Adjuvans während der konventionellen Chemotherapie indiziert? Forsch Komplementärmed Klass Naturheilkd.
    4. (1995). Effects of Viscum album L. on cyclophosphamide-treated peripheral blood mononuclear cells in vitro: sister chromatid exchanges and activation/proliferation marker expression. Cancer Lett.
    5. (2008). Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw.
    6. (2006). Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer.
    7. (2004). Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res.
    8. (2001). Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.
    9. (2004). Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med.
    10. (2007). Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials? Evid Based Complement Alternat Med.
    11. (2000). NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park).
    12. (1999). Nichtparametrische Analyse longitudinaler Daten. München: Oldenbourg Verlag;
    13. (2006). Palliative in-patient cancer treatment in an anthroposophic hospital: I. Treatment patterns and compliance with anthroposophic medicine. Forsch Komplementarmed.
    14. (2004). Placebo interventions for all clinical conditions. Cochrane Database Syst Rev.
    15. (2004). Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol.
    16. (2000). Problems of randomised treatment studies in complementary medicine.
    17. (2004). Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst.
    18. (2006). Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Res.
    19. (2006). Quality of sleep and related factors during chemotherapy in patients with stage I/II breast cancer. J Formos Med Assoc.
    20. (2004). Randomized and double-blind studies—demands and reality as demonstrated by two examples of mistletoe research. Forsch Komplementarmed Klass Naturheilkd.
    21. (2005). Signifikant höherer Anteil aktivierter NK-Zellen durch additive Misteltherapie bei chemotherapierten Mamma-CA-Patientinnen in einer prospektiven randomisierten doppelblinden Studie. In: Scheer
    22. (1995). The dual role of Viscum album L. effects: cytostatic and DNA stabilizing properties. Eur J Allerg Clin Immun.
    23. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst.
    24. (2004). The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebocontrolled, double-blind, multicentre clinical trial. Anticancer Res.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.